⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27668670 | 0.86 | — | — | |
| Iodide SCHEMBL28263957 | 0.86 | — | — | |
| SCHEMBL28115973 | 0.86 | — | — | |
| SCHEMBL25237674 | 0.86 | — | — | |
| Fluoride SCHEMBL28286796 | 0.86 | — | — | |
| SCHEMBL23244632 | 0.86 | — | — | |
| SCHEMBL28000909 | 0.86 | — | — | |
| SCHEMBL27826407 | 0.86 | — | — | |
| Fluoride SCHEMBL28184212 | 0.86 | — | — | |
| Hydrochloric Acid SCHEMBL27903023 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180263940-A1 | TREATMENT OF SKIN CONDITIONS | MONASH UNIVERSITY (AU) | 2018-09-20 | — | — | US | disclosed |
| EP-3271017-A1 | TREATMENT OF SKIN CONDITIONS | Monash University (AU) | 2018-01-24 | — | — | EP | disclosed |
| WO-2016145488-A1 | TREATMENT OF SKIN CONDITIONS | MONASH UNIVERSITY (AU) | 2016-09-22 | — | — | WO | disclosed |
| EP-0761646-B1 | Preparation of alkanesulfonamides with low residual ammonium impurities | ATOCHEM NORTH AMERICA ELF (US) | 1999-10-27 | — | — | EP | disclosed |
| EP-0761646-A1 | Preparation of alkanesulfonamides with low residual ammonium impurities | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1997-03-12 | — | — | EP | disclosed |
| US-5599983-A | Preparation of alkanesulfonamides with low residual ammonium impurities | ARKEMA INC. | 1997-02-04 | — | — | US | disclosed |